Registering children's rash illnesses to improve diagnosis
Part of Infections, Skin clinical trials.
This study is for children and teens up to 18 years old who have a fever and a rash, possibly from infections like measles, rubella, dengue, or chikungunya. It helps doctors better understand these illnesses and how to tell them apart, using a simple blood or swab test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years old or younger (any age from newborn to 18).
- Must have certain symptoms: fever plus a rash, and sometimes cough, runny nose, or red eyes.
- Symptoms may also include joint pain, headache, nausea, or small red spots under the skin.
- A blood or swab sample must have been taken for lab testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if giving measles-rubella and yellow fever vaccines together on the same day is safe and works well for babies. It is for healthy infants aged 9-12 months who have not had these vaccines before. The goal is to see if giving both at once is a good option for protecting babies.
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
This study tests a new rapid diagnostic tool that can quickly identify tropical fever-causing infections like malaria, dengue, Zika, chikungunya, or leptospirosis from a blood sample. The goal is to help doctors diagnose these infections faster so patients can get treatment sooner.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
This study looks at patients with suspected, probable, or confirmed arbovirus infections (like dengue, chikungunya, or Zika) to understand what factors lead to hospitalization and how severe the illness can be. It may include adults, children, and even newborns if they might have been exposed.
Hear when a new Dengue Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.